key: cord-0967570-ev26nof2
authors: de Lange, M.; Carvalho, A. S.; Brito Fernandes, O.; Lingsma, H.; Klazinga, N.; Kringos, D.
title: The impact of the COVID-19 pandemic on hospital services for patients with cardiac diseases: a scoping review
date: 2021-12-02
journal: nan
DOI: 10.1101/2021.12.01.21267100
sha: 9c7077056e302ff39da7d11c4618ea75e037d5ad
doc_id: 967570
cord_uid: ev26nof2

Aim: To assess the impact of the COVID-19 pandemic on hospital care for cardiac patients. Methods and results: Scoping review, including studies with empirical data on changes in the use of health services measured by performance indicators during January - June 2020. Database searches yielded 6277 articles, of which 838 articles met the inclusion criteria during initial screening. After full-text screening, 94 articles were considered for data extraction. In total, 1637 indicators were retrieved, showing large variation in the indicators and their definitions. Most of the indicators that provided information on changes in number of admissions (n=118, 88%) signalled a decrease in admissions; 88% (n=15) of the indicators showed patients delayed presentation and 40% (n=54) showed patients in a worse clinical condition. A reduction in diagnostic and treatment procedures was signalled by 95% (n=18) and 81% (n=64) of the indicators reporting on cardiac procedures, respectively. Length of stay decreased in 58% (n=21) of the indicators and acute coronary syndromes treatment times increased in 61% (n=65) of the indicators. Outpatient activity decreased in 94% (n=17) of the indicators related with outpatient care, whereas telehealth utilization increased in 100% (n=6). Outcomes worsened in 40% (n=35) of the indicators, and mortality rates increased in 52% (n=31). Conclusion: All phases of the hospital cardiac care pathway were affected. This information could support the planning of care during the ongoing pandemic and in future events. Furthermore, to ensure continuity of care during crises, fostering the use of standardised indicators is paramount.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Introduction novel models of care. Given the burden of cardiac diseases in healthcare systems globally (22, 23) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint

In a relatively short period, large amounts of scientific evidence have become available on the impact 1 of the pandemic on patients with cardiac diseases in varying countries. This literature is scattered, which 2 makes it difficult to draw conclusions regarding the impact on cardiac care delivery and the use of data 3 to steer health care services delivery improvements during the current pandemic and future public health 4 crises. Hence, reviewing the existing literature and quantifying the magnitude of this impact helps to 5 systematize, synthesize, and consolidate the evidence, and to formulate recommendations for policy and 6 practice. 7 This scoping review is part of a larger project that focuses on performance indicators used for a range 8 of clinical areas during the COVID-19 pandemic. In this study, we aim to assess the impact of the 9 pandemic on hospital care for cardiac patients in OECD countries, focusing on the different phases of 10 the hospital cardiac care pathway (admission, diagnosis, treatment, outpatient care, outcomes). 11 12 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint 5 Methods 1 2 We pursued a scoping review methodology, considering the extensive number of scientific articles, their 3 heterogeneous character, and the lack of a clear and structured overview of the large sums of literature 4 that have become available on the impact of the pandemic on patients with cardiac conditions. A scoping 5 review can be used to examine emerging evidence and give an overview of the literature and studies 6 available on a certain theme (29). We followed the methodological framework developed by Arksey 7 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint

The following inclusion criteria were set: 1) studies using empirical data on the use of health services; 2 2) studies had to describe health outcomes and/or performance indicators during the COVID- 19 3 pandemic; 3) studies that are presented as original journal articles using quantitative or qualitative 4 methods, such as cohort studies, case-control, cross-sectional designs, case reports, systematic reviews, 5 surveys, and meta-analyses. The following exclusion criteria were set: 1) non-primary studies (such as 6 editorials and commentaries); 2) prediction models; 3) clinical case reports; and 4) diseases management 7 or health services organization guidelines; 5) studies about the impact on healthcare workers, patients 8 diagnosed with COVID-19, children, or pregnant women; 6) studies primarily performed in non-OECD 9 countries; 7) articles from which only an abstract was available. 10 11

An initial screening of the retrieved studies based on title and abstract was performed independently by 13 two researchers (ASC, OBF) using Rayyan (https://www.rayyan.ai/). Studies considered relevant after 14 this phase were exported to a spreadsheet to support full-text screening, which was performed 15 independently by three researchers (MdL, ASC, OBF). For this study only articles on cardiac diseases 16 were analysed. The reason for exclusion of articles was recorded at this point. In case of doubt, the other 17 co-authors were consulted, and a decision was made. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint

Database searches yielded 6277 articles. Of these, 838 articles focusing on non-communicable diseases 2 met the inclusion criteria. After full-text screening of 117 articles focused on cardiac hospital care, a 3 total of 94 articles were included in this review (Fig. 1) . Twenty-three full-text studies were excluded. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint

The included articles reported on 109 different countries (Fig. 2) . Eighty-six articles provided 2 information on one country only. Eight articles involved multiple countries, of which seven also 3 included non-OECD countries. Most articles reported on Italy (n = 20, 21%), followed by the United 4 Kingdom (n = 17, 18%), and Germany (n = 14, 15%). 19 affected period in 2020 to the same period in the previous year (n = 54, 56%). Other studies (n = 34, 14 36%) compared the COVID-19 affected period to a period immediately before. Lastly, a COVID- 19 15 affected period was compared to the average of the same period in several previous years (n = 27, 29%). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint Impact of COVID-19 on the hospital cardiac care pathway 1 2

The indicators were categorised and grouped according to different phases of the hospital cardiac care 3 pathway (Fig. 3) , to visualise their combined trends. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint in number of admissions, compared to a non-COVID-19 period, 13 indicators (9.7%) reported a stable 1 number of admissions, whereas 3 indicators (2.2%) reported an increase in admission numbers. 2 3

Regarding the patients' timing of presentation to hospital services, 17 indicators were identified from 5 12 articles (43,50,55,68,79,82-88). All the indicators in this category reported on patients with ACS. 6

Most indicators defined delayed presentation as more than twelve hours after symptom onset. Of these 7 indicators, 15 (88%) reported an increase of the number of patients with a delayed presentation to 8 hospital services for cardiac care compared to a non-COVID-19 period. One indicator (5.9%) reported 9 a stable number of patients with a delayed presentation, and one indicator a decrease. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint times reported in the papers were symptom-to-contact, symptom-to-door, symptom-to-diagnosis, 23 symptom-to-balloon (total ischaemia time), contact-to-door, contact-to-balloon, door-to-ECG, door-to-24 balloon, ECG-to-balloon, diagnosis-to-balloon, first medical contact-to-catheter laboratory arrival, 25 catheter-to-puncture, catheter laboratory arrival-to-balloon, puncture-to-balloon, and procedure time. Of 26 these indicators, 65 (61%) reported an increase in ACS treatment pathway times during the COVID- 19 27 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint A total of 24 indicators regarding the 'outpatient care' phase of the cardiac care pathway were identified. 5

These indicators were grouped into two separate categories: 'outpatient activity' and 'telehealth'. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint indicators mainly concerned in-hospital mortality or 30-day case mortality rates. Of these indicators, 31 10 (52%) reported an increase in mortality rates during the COVID-19 period, 26 (43%) reported stable 11 mortality rates, and 3 indicators (5%) show decreased mortality rates. 12 13 An overview of the trends reported by the indicators in each phase of the hospital cardiac care pathway 14 (defined as desirable, undesirable, or stable, following clinical reasoning) is shown in Fig. 4 . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint hospital bed capacity or the physicians' intention to minimise the risk of patients' exposure to the virus. 1

For instance, the European Society of Cardiology recommended that patients "should stay in the hospital 2 for the shortest time possible" (128), and healthcare providers in the United Kingdom were advised to 3 reduce NSTEMI inpatient stays to 36-48 hours if normal pathways could not be followed (61). The 4 increased ACS treatment pathway times and the decreased length of stay, together, indicate that the 5 hospital cardiac care pathway was under pressure during the COVID-19 pandemic and the delivery of 6 care got squeezed. 7

The reduction in outpatient care volume we show in this study mostly comes from indicators reporting 8 on in-patient visits. Therefore, it is probably an underestimation of the actual outpatient care provided. 9

The change towards using telehealth shows that innovative measures were taken during the pandemic 10 to avoid the risk of SARS-CoV-2 infection, and health systems adapted quickly to reach out to patients 11 with other means than in-person consultations. In theory, strengthening the use of telehealth to provide 12 continuity of care is beneficial. However, little is known about the quality of care provided and potential 13 inequalities that may have risen from the use of telehealth (e.g., access for all patient groups). 14 Our findings suggest patients with cardiac conditions are showing worse outcomes and increased 15 mortality rates during the COVID-19 pandemic. The indicators that reported changes on mortality 16 mostly concerned short-term mortality rates (up to 30 days). An even larger impact on mortality might 17 be found when long-term mortality rates will be assessed in later studies. These studies will have to 18 contribute to capturing the real impact that this paper has outlined. The repercussions of care avoidance 19 and cancelled or delayed diagnostic and treatment procedures could reveal itself in the years to come. 20

To our knowledge, this is the first scoping review that gives an overview of the impact of the COVID- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint compare data in a reliable way. In July 2020, the International Training Network for Healthcare 1 Performance Intelligence Professionals (HealthPros) (129) suggested that to compare, manage and 2 improve health systems responsiveness to the pandemic, commonly agreed-upon standardized data and 3

indicators are necessary (130). We recommend devising a uniformly accepted set of indicators with 4 clear definitions to use in future pandemics. 5

Another limitation is that only articles reporting on OECD countries were included in this scoping 6 review. The global repercussions of the COVID-19 pandemic on hospital services for cardiac care will 7 therefore likely be larger than reported in this paper, given the smaller capacity to handle changes in 8 hospital care in low-income countries. On the other hand, publication bias may have played a role in 9 portraying a more severe impact of the pandemic. Physicians might publish sooner when effects of the 10 pandemic are being clearly noticed in their hospital. It could also be the case that the overload with 11 clinical tasks did not allow physicians to find the time to do scientific work, which may counterbalance 12 this limitation. Regardless, we consider our findings to be useful and signalling major trends. 13

Based on the included articles we are not able to provide an analysis of what exactly caused these 14 changes in the hospital cardiac care pathway. Being able to contextualise these results with future 15 research will be of use for implementing measures to improve care during the current and future 16 pandemics or disasters. We also welcome studies on the quality and access of telemedicine during the 17 COVID-19 pandemic. It would be relevant to study if and how this could improve quality and access of 18 services delivery for the better, also in non-crisis times. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint essential care during future crises, fostering the use of an international standardised set of indicators is 1 paramount, making optimal use of existing health information infrastructures. 2 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. MdL and ASC contributed equally as co-first authors to the development and execution of this study. 19

The authors wish to thank Wichor Bramer from the Erasmus MC Medical Library for developing and 20 updating the search strategies used in this study. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint from the European Union's Horizon 2020 research and innovation programme under grant agreement 1

Nr. 765141 (https://healthpros-h2020.eu). 2 3

The authors declare that they have no competing interests. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint

A new coronavirus associated with human respiratory disease in China

Listings of WHO's response to COVID-19

Ranking the effectiveness of worldwide COVID-19 government interventions

Understanding Vaccination Progress by Country

Projecting hospital utilization during the COVID-19 outbreaks in the 14 United States

International guidelines and recommendations for surgery during Covid-19 17 pandemic: A Systematic Review

Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease

Remote cardiac rehabilitation is a good alternative of outpatient cardiac 1 rehabilitation in the COVID-19 era

Population-level impact of 3 coronavirus disease 2019 on breast cancer screening and diagnostic procedures

Global Survey on Pancreatic Surgery During the COVID-19 Pandemic

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute 8 Admissions at the Emergency and Cardiology Departments Across Europe

The corona-virus disease 2019 pandemic compromised routine care for 11 hypertension: a survey conducted among excellence centers of the European Society of Hypertension

Assessing the Indirect Effects

on Healthcare Delivery, Utilization, and Health Outcomes: A Scoping Review

The impact of COVID-19 on breast cancer stage at diagnosis

Scoping studies: advancing the methodology

Checklist and Explanation

REDUCED RATE OF HOSPITAL PRESENTATIONS FOR HEART FAILURE 6 DURING THE COVID-19 PANDEMIC IN TORONTO

Impact of the COVID-19 Pandemic on Hospitalizations 9 for Acute Coronary Syndromes: a Multinational Study

Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular 11 diseases in the UK

Fewer Hospitalizations for Acute Cardiovascular Conditions During the 13 COVID-19 Pandemic

Effect of COVID-19 on acute treatment of ST-segment elevation and 15

-segment elevation acute coronary syndrome in northwestern Switzerland

In-hospital mortality in heart failure in 18 Germany during the Covid-19 pandemic

The impact of COVID-19 on heart failure hospitalization and management: report 21 from a Heart Failure Unit in London during the peak of the pandemic

All-cause mortality and location of death in patients with established cardiovascular 1 disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study

Impact of COVID-19-related public containment measures on the ST elevation 5 myocardial infarction epidemic in Belgium: a nationwide, serial, cross-sectional study

The Impact of the Coronavirus Disease-2019 Pandemic 8 and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure

Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak 12 in Northern Italy

Impact of COVID-19 on inpatient referral of acute heart failure: a single-centre 14 experience from the south-west of the UK

Treatment delays and in-hospital outcomes in acute myocardial infarction 17 during the COVID-19 pandemic: A nationwide study

COVID-19 impact on ST-elevation myocardial infarction incidence rate in a Italian 20 STEMI network: a U-shaped curve phenomenon

Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary 1 syndrome in Veneto region

Effects of the coronavirus disease 2019 pandemic on the number of 4 hospitalizations for myocardial infarction: regional differences. Population analysis of 7 million people

Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-7 ACS admissions

Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial 10

Infarction During the Coronavirus Disease 2019 Pandemic

ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: 12 Insights From a Regional Public Service Healthcare Hub

Impact of a nationwide COVID-19 lockdown on acute coronary syndrome referrals

The effect of the COVID-19 pandemic on acute coronary 18 syndrome hospitalizations and out-of-hospital cardiac arrest in Greece

Comparison of the number of cardiovascular admissions before and after covid-19: Experience from 21 Turkey

COVID-19 pandemic and admission rates for and management of acute 3 coronary syndromes in England

Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey

Age and Gender influence on time of arrival for STEMI patients during Covid-10 19 pandemic

Impact of the COVID-19 pandemic on cardiovascular mortality and catherization 13 activity during the lockdown in central Germany: an observational study

Impact of COVID-19 pandemic in cardiology admissions

Missing" acute coronary syndrome hospitalizations during the COVID-19 19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

Increased cardiovascular death rates in a COVID-19 low prevalence area. The 22

Increased mortality and worse cardiac outcome of acute myocardial infarction 25 during the early COVID-19 pandemic

31 days of COVID-19-cardiac events during restriction of public life-a 1 comparative study

Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST

Segment Elevation Myocardial Infarction

Impact of the COVID-19 pandemic on interventional 7 cardiology practice: results of the EAPCI survey

The Impact of the COVID-19 Pandemic on Incidences of Atrial

Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter-and Intra-year Analysis

Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 12 2020 SARS-CoV-2 Pandemic

Impact of COVID-19 on acute coronary syndrome-related 15 hospitalizations: A pooled analysis

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute 18 Admissions at the Emergency and Cardiology Departments Across Europe

The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction

Impact of the COVID-19 pandemic on admissions for 1 acute coronary syndrome: review of the literature and single-center experience

The Decrease in Hospitalizations For Heart Failure During the Covid-19 Pandemic: 4 A Community and Academic Hospital Comparison Study

Patient response, treatments, and mortality for acute myocardial infarction during the 7 COVID-19 pandemic

Delays in Presentation in Patients With Acute Myocardial Infarction During the 10 COVID-19 Pandemic

Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a 12 non-COVID-19 epicenter

COVID-19 pandemic is associated with mechanical complications in patients with 14 ST-elevation myocardial infarction

Impact of the COVID-19 pandemic on acute coronary syndromes

Acute coronary syndromes undergoing 18 percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital 19 presentation

Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial 21

Infarction Presentations and In-Hospital Outcomes

Cardiac procedural deferral during the coronavirus (COVID-19) pandemic. Catheter 24

Mortality in STEMI Patients During the COVID Era: Has the Pandemic

Changed Our Clinical Practice?

COVID-19 and changes in activity and treatment of ST elevation MI from a UK 4 cardiac centre

Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in 6 patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-9 19 era

Implications of COVID-19 on Time-Sensitive STEMI Care: A 11 Report From a North American Epicenter

Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome 15 admissions: four weeks to reverse the trend

The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing 18 of presentation and early outcomes of patients with ST-elevation myocardial infarction

Impact of COVID-19 on percutaneous coronary intervention for ST-elevation 21 myocardial infarction

Impact of the COVID-19 pandemic on acute myocardial infarction care times

Changes in characteristics and management 3 among patients with ST-elevation myocardial infarction due to COVID-19 infection

Impact of COVID-19 on ST-segment elevation myocardial 6 infarction care. The Spanish experience

Impact of COVID-19 outbreak on regional STEMI care in Germany

Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic 12 heart disease

Catheterization laboratory activity before and during COVID-19 spread: A 15 comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE)

The impact of the COVID-19 pandemic on cardiac surgery and transplant services in 18

Ireland's National Centre

Decreases in cardiac catheter laboratory workload during the COVID-19 level 4 lockdown in 21

Implementation of Percutaneous Coronary Intervention

During the COVID-19 Pandemic in Japan -Nationwide Survey Report of the Japanese Association of Cardiovascular 2 Intervention and Therapeutics for Cardiovascular Disease

Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in

Insights From the British Cardiovascular Intervention Society PCI Database Cohort

In-Hospital and 30-Day Mortality After Percutaneous Coronary Intervention 7 in England in the Pre-COVID and COVID Eras

COVID-19 on cardiovascular surgery services in Spain (SECCE-COVID19 Study

Impact of COVID-19 outbreak and public lockdown on ST-14 segment elevation myocardial infarction care in Spain

European Society of Hypertension Corona-virus Disease 19 Task Force. The corona-virus disease 2019 pandemic 18 compromised routine care for hypertension

The impact of COVID-19 on the management of 21 heart failure: a United Kingdom patient questionnaire study

Impact of lockdown on patients with congestive heart failure during the coronavirus 25 disease 2019 pandemic

Czeisler MÉ. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns -United States

Environmental determinants of cardiovascular disease: lessons 6 learned from air pollution

COVID-19 lockdowns cause global air pollution declines

Where Have All the Heart Attacks Gone?

Coronavirus doctor's diary: Is lockdown good for your heart?

COVID-19 and cardiac surgery: The perspective from United Kingdom

The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the 19 COVID-19 Pandemic

Managing COVID-19 within and across health systems: why we need 25 performance intelligence to coordinate a global response

It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint It is made available under a perpetuity.is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprintThe copyright holder for this this version posted December 2, 2021. ; https://doi.org/10.1101/2021.12.01.21267100 doi: medRxiv preprint